AMN vs. RCM, CRVL, AMED, MD, CCRN, LH, DGX, DVA, CHE, and RHI
Should you be buying AMN Healthcare Services stock or one of its competitors? The main competitors of AMN Healthcare Services include R1 RCM (RCM), CorVel (CRVL), Amedisys (AMED), Pediatrix Medical Group (MD), Cross Country Healthcare (CCRN), Laboratory Co. of America (LH), Quest Diagnostics (DGX), DaVita (DVA), Chemed (CHE), and Robert Half (RHI).
AMN Healthcare Services (NYSE:AMN) and R1 RCM (NASDAQ:RCM) are both mid-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, profitability, media sentiment, community ranking, earnings and dividends.
AMN Healthcare Services has a beta of 0.17, suggesting that its stock price is 83% less volatile than the S&P 500. Comparatively, R1 RCM has a beta of 0.86, suggesting that its stock price is 14% less volatile than the S&P 500.
In the previous week, AMN Healthcare Services had 3 more articles in the media than R1 RCM. MarketBeat recorded 6 mentions for AMN Healthcare Services and 3 mentions for R1 RCM. R1 RCM's average media sentiment score of 1.32 beat AMN Healthcare Services' score of 0.39 indicating that R1 RCM is being referred to more favorably in the news media.
99.2% of AMN Healthcare Services shares are held by institutional investors. Comparatively, 61.1% of R1 RCM shares are held by institutional investors. 0.9% of AMN Healthcare Services shares are held by insiders. Comparatively, 36.8% of R1 RCM shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.
AMN Healthcare Services has higher revenue and earnings than R1 RCM. R1 RCM is trading at a lower price-to-earnings ratio than AMN Healthcare Services, indicating that it is currently the more affordable of the two stocks.
AMN Healthcare Services has a net margin of 4.13% compared to R1 RCM's net margin of -1.39%. AMN Healthcare Services' return on equity of 31.39% beat R1 RCM's return on equity.
AMN Healthcare Services presently has a consensus target price of $75.57, suggesting a potential upside of 40.62%. R1 RCM has a consensus target price of $16.31, suggesting a potential upside of 27.90%. Given AMN Healthcare Services' higher probable upside, research analysts plainly believe AMN Healthcare Services is more favorable than R1 RCM.
AMN Healthcare Services received 157 more outperform votes than R1 RCM when rated by MarketBeat users. Likewise, 68.87% of users gave AMN Healthcare Services an outperform vote while only 57.94% of users gave R1 RCM an outperform vote.
Summary
AMN Healthcare Services beats R1 RCM on 12 of the 18 factors compared between the two stocks.
Get AMN Healthcare Services News Delivered to You Automatically
Sign up to receive the latest news and ratings for AMN and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding AMN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
AMN Healthcare Services Competitors List
Related Companies and Tools
